Pharmaceutical Traceability Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Published: Dec 2023 Pages: 176 SKU: IRTNTR44798

Pharmaceutical Traceability Market 2024-2028

The global pharmaceutical traceability market size is estimated to grow by USD 17.92 billion at a CAGR of 23.44% between 2023 and 2028. 

Globally, pharmaceutical companies are witnessing significant growth. The increasing prevalence and incidence of various chronic diseases, such as cancer, heart disease, diabetes, arthritis, chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and dementia, have increased the need to develop new drugs for their treatment. To treat these chronic diseases, pharmaceutical companies are increasingly focusing on developing generic and over-the-counter (OTC) drugs for various therapeutic applications. Further, rapid growth in drug development has increased the need for pharmaceutical companies to ensure brand protection due to counterfeiting. This is increasing the demand for various advanced technologies, including printing technologies and digital scanning, to protect pharmaceutical products from counterfeiting. Hence, the rising focus of pharmaceutical companies on brand protection is fostering the growth of the market during the forecast period.

Technavio has segmented the market into Type, Application, and Geography

  • The type segment is classified into barcode, RFID, GPS, and biometrics and others
  • The application segment is classified into pharmaceutical factories, hospitals, pharmacies, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Pharmaceutical Traceability Market During the Forecast Period?

To learn more about this report, Download Report Sample

Pharmaceutical Traceability Market Segmentation by Type, Application and Geography Analysis

Type Analysis 

Barcode

The market share growth by the barcode segment will be significant during the forecast period. Barcodes are a series of vertical lines or bars with different widths that can be read by an optical scanner. The width and spacing of the bars represent binary data. The scanners are connected to computers. These scanners decode the barcodes to give the necessary information regarding the product.

Get a glance at the market contribution of various segments Download PDF Sample

The barcode was the largest segment and was valued at USD 1.71 billion in 2018. Barcodes have been widely accepted by end-users because of their relatively lower cost when compared with RFID tags, their lightweight nature for ease of use, and their high accuracy levels on different material surfaces. Also, the government has promoted the use of barcodes in the pharmaceutical industry by introducing new initiatives and laws. Barcodes facilitate efficient tracking and identification of pharmaceutical products, aiding in supply chain management and reducing the risk of counterfeit drugs. Additionally, regulatory mandates for serialization and traceability further propel the growth of barcode solutions, making them a practical and widely accepted technology in pharmaceutical traceability efforts worldwide. Such factors will fuel the growth of the barcode segment of the market during the forecast period.

Application

Pharmaceutical factories

The pharmaceutical factories segment in the global pharmaceutical traceability market is witnessing increased demand due to several compelling factors. Firstly, regulatory compliance is a major driver in the growth of the pharmaceutical factories segment, as pharmaceutical manufacturers must adhere to stringent regulations to ensure the safety and authenticity of their products. Secondly, the rising prevalence of counterfeit drugs is a significant concern in the pharmaceutical industry.  Pharmaceutical factories are adopting traceability solutions to enhance operational efficiency and supply chain visibility. Accurate tracking and monitoring of the production processes, inventory, and distribution contribute to streamlined operations, reduced errors, and improved overall efficiency. Thus, stringent regulatory requirements, the need to combat counterfeit drugs, and a focus on enhancing operational efficiency will drive the growth of the global pharmaceutical traceability market through the pharmaceutical factories segment during the forecast period.

Hospitals

The hospital segment in the global pharmaceutical traceability market is witnessing increased demand due to various factors contributing to the overall safety, efficiency, and effectiveness of healthcare delivery. Patient safety is paramount in hospitals, and accurate traceability ensures that the right medications are administered to the right patients at the right time. Further, instances of increasing demand for pharmaceutical traceability in hospitals include the adoption of barcoding systems for patient identification and medication administration. Barcodes on patient wristbands and medications enable healthcare providers to verify patient identities and match them with prescribed medications, reducing the risk of errors during the administration process. This enhanced traceability in hospitals contributes to a safer and more efficient healthcare environment. Thus, increased emphasis on patient safety, efficient inventory management, and regulatory compliance will drive the demand for pharmaceutical traceability solutions in hospitals and will fuel the growth of the market in focus during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Rapid growth in the development of pharmaceutical drugs, technological advances, growing outsourcing of pharmaceutical manufacturing activities, rising concerns over the proliferation of counterfeit drugs, stringent regulations, and government initiatives, and the presence of prominent companies are the major factors driving the growth of the pharmaceutical traceability market in North America. In addition, pharmaceutical companies are outsourcing the development and manufacturing of pharmaceutical drugs to CMOs and contract development and manufacturing organizations (CDMOs), which is also increasing the demand for pharmaceutical traceability solutions and thereby boosting the growth of the pharmaceutical traceability market in North America.

Additionally, the DSCSA relates to the serialization of manufacturing drug products in the US and aims at tracking and tracing certain prescription drugs, which, in turn, has increased the demand for pharmaceutical traceability, thus spurring the growth of the pharmaceutical traceability market in North America during the forecast period.

Buy Full Report Now

Key Pharmaceutical Traceability Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

AlpVision SA  - The company offers pharmaceutical traceability solutions namely Pharmaledger.

  • Antares Vision S.p.A
  • Authentix Inc.
  • Avery Dennison Corp.
  • Axway Software SA
  • Bar Code India Ltd.
  • Cognex Corp.
  • Controlant hf.
  • Datalogic SpA
  • Dover Corp.
  • Impinj Inc.
  • Logista Pharma SAU
  • Mettler Toledo International Inc.
  • Optel Group, Oracle Corp.
  • rfxcel Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Pharmaceutical Traceability Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Pharmaceutical Traceability Market Drivers

Government regulations and initiatives regarding counterfeit drugs and medicines are notably driving the market growth. The rise in the global counterfeit of drugs and medicines has led the governments of various nations to introduce regulations to improve the traceability of pharmaceutical products. To reduce the growing market for counterfeit drugs, various governments and authorities in several nations have taken initiatives by declaring deadlines for implementing serialization by pharmaceutical companies. For example, in the US, the DSCSA made it mandatory that pharmaceutical companies introduce serial codes while manufacturing drugs, both at the saleable unit and case level, for manufacturers and re-packagers. 

Similarly, in July 2019, the Therapeutic Goods Administration (TGA) in Australia introduced new guidelines on product coding to reduce the counterfeiting of drugs in the country. Thus, the various government regulations and initiatives will drive the demand for the implementation of global traceability systems to overcome the various counterfeit issues and, in turn, will boost the growth of the market during the forecast period.

Significant Pharmaceutical Traceability Market Trends

The growth of online pharmacies is an emerging trend shaping the market growth. An online pharmacy or e-pharmacy uses an online platform for connecting a customer and seller for the sales of medicines. E-pharmacies are growing because of the discounts available on the products. Also, the customers can have easy access to the products because they are delivered to the customer as and when required. Some of the major factors driving the market are the growing number of Internet users and changing purchase preferences, that is, the growing number of online purchases.

Moreover, the sale of counterfeit drugs imposes a huge threat to the patient's life as well as the reputation of the company that manufactures the original drug. The growth of online pharmacies is the main source of counterfeit drugs; hence, this trend will give rise to the need for appropriate traceability systems in place and, in turn, will propel the growth of the market during the forecast period.

Major Pharmaceutical Traceability Market Challenges

The growing need for system integration is a significant challenge hindering the market growth. For a proper track and trace system, the state and central governments must be integrated into a single system. The integrated system must connect the government agencies, manufacturers, and other players in the supply chain. This task involves substantial setting up and implementation costs. Also, the integrated system becomes complex when more serial codes are assigned at unit levels and must be tracked throughout the supply chain. Also, the assignment of unique serial numbers at the unit level generates a huge amount of data.

Furthermore, huge investments are required for the development of such systems because updating existing hardware, software, and equipment is also required. The implementation of serialization can reach an estimated cost of around USD 2 million. The technical issues and difficulties in integrating the system will obstruct the adoption of such systems. Such challenges will slow down the growth of the market in focus during the forecast period.

Buy Now Full Report

Key Pharmaceutical Traceability Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Pharmaceutical Traceability Market Customer Landscape

Segment Overview

The pharmaceutical traceability market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Type Outlook
    • Barcode
    • RFID
    • GPS
    • Biometrics and others
  • Application Outlook
    • Pharmaceutical factories
    • Hospitals
    • Pharmacies
    • Others
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Australia

Pharmaceutical Traceability Market Scope

Report Coverage

Details

Page number

176

Base year

2023

Historic period

 2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 23.44%

Market Growth 2024-2028

USD 17.92 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

23.38

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Germany, France, UK, and China

Competitive landscape

Leading Comapnies, Market Positioning of Comapnies, Competitive Strategies, and Industry Risks

Key companies profiled

AlpVision SA, Antares Vision S.p.A, Authentix Inc., Avery Dennison Corp., Axway Software SA, Bar Code India Ltd., Cognex Corp., Controlant hf., Datalogic SpA, Dover Corp., Impinj Inc., Logista Pharma SAU, Mettler Toledo International Inc., Optel Group, Oracle Corp., rfxcel Corp., SAP SE, SATO Holdings Corp., TraceLink Inc., and Zebra Technologies Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Pharmaceutical Traceability Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the pharmaceutical traceability market  between 2024 and 2028
  • Precise estimation of the size of the pharmaceutical traceability market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of pharmaceutical traceability market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global pharmaceutical traceability market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global pharmaceutical traceability market 2018 - 2022 ($ billion)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.3 Application Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Barcode - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Barcode - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Barcode - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Barcode - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Barcode - Year-over-year growth 2023-2028 (%)
    • 6.4 RFID - Market size and forecast 2023-2028
      • Exhibit 38: Chart on RFID - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on RFID - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on RFID - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on RFID - Year-over-year growth 2023-2028 (%)
    • 6.5 GPS - Market size and forecast 2023-2028
      • Exhibit 42: Chart on GPS - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on GPS - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on GPS - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on GPS - Year-over-year growth 2023-2028 (%)
    • 6.6 Biometrics and others - Market size and forecast 2023-2028
      • Exhibit 46: Chart on Biometrics and others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 47: Data Table on Biometrics and others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 48: Chart on Biometrics and others - Year-over-year growth 2023-2028 (%)
      • Exhibit 49: Data Table on Biometrics and others - Year-over-year growth 2023-2028 (%)
    • 6.7 Market opportunity by Type
      • Exhibit 50: Market opportunity by Type ($ billion)
      • Exhibit 51: Data Table on Market opportunity by Type ($ billion)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 52: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 53: Data Table on Application - Market share 2023-2028 (%)
    • 7.2 Comparison by Application
      • Exhibit 54: Chart on Comparison by Application
      • Exhibit 55: Data Table on Comparison by Application
    • 7.3 Pharmaceutical factories - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Pharmaceutical factories - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Pharmaceutical factories - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Pharmaceutical factories - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Pharmaceutical factories - Year-over-year growth 2023-2028 (%)
    • 7.4 Hospitals - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.5 Pharmacies - Market size and forecast 2023-2028
      • Exhibit 64: Chart on Pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Data Table on Pharmacies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 66: Chart on Pharmacies - Year-over-year growth 2023-2028 (%)
      • Exhibit 67: Data Table on Pharmacies - Year-over-year growth 2023-2028 (%)
    • 7.6 Others - Market size and forecast 2023-2028
      • Exhibit 68: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 70: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 71: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.7 Market opportunity by Application
      • Exhibit 72: Market opportunity by Application ($ billion)
      • Exhibit 73: Data Table on Market opportunity by Application ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 France - Market size and forecast 2023-2028
      • Exhibit 107: Chart on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 108: Data Table on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 109: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 110: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.11 UK - Market size and forecast 2023-2028
      • Exhibit 111: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 112: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 113: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 114: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ billion)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 AlpVision SA
              • Exhibit 123: AlpVision SA - Overview
              • Exhibit 124: AlpVision SA - Product / Service
              • Exhibit 125: AlpVision SA - Key offerings
            • 12.4 Antares Vision S.p.A
              • Exhibit 126: Antares Vision S.p.A - Overview
              • Exhibit 127: Antares Vision S.p.A - Product / Service
              • Exhibit 128: Antares Vision S.p.A - Key offerings
            • 12.5 Authentix Inc.
              • Exhibit 129: Authentix Inc. - Overview
              • Exhibit 130: Authentix Inc. - Product / Service
              • Exhibit 131: Authentix Inc. - Key offerings
            • 12.6 Avery Dennison Corp.
              • Exhibit 132: Avery Dennison Corp. - Overview
              • Exhibit 133: Avery Dennison Corp. - Business segments
              • Exhibit 134: Avery Dennison Corp. - Key news
              • Exhibit 135: Avery Dennison Corp. - Key offerings
              • Exhibit 136: Avery Dennison Corp. - Segment focus
            • 12.7 Cognex Corp.
              • Exhibit 137: Cognex Corp. - Overview
              • Exhibit 138: Cognex Corp. - Product / Service
              • Exhibit 139: Cognex Corp. - Key offerings
            • 12.8 Controlant hf.
              • Exhibit 140: Controlant hf. - Overview
              • Exhibit 141: Controlant hf. - Product / Service
              • Exhibit 142: Controlant hf. - Key offerings
            • 12.9 Datalogic SpA
              • Exhibit 143: Datalogic SpA - Overview
              • Exhibit 144: Datalogic SpA - Business segments
              • Exhibit 145: Datalogic SpA - Key offerings
              • Exhibit 146: Datalogic SpA - Segment focus
            • 12.10 Dover Corp.
              • Exhibit 147: Dover Corp. - Overview
              • Exhibit 148: Dover Corp. - Business segments
              • Exhibit 149: Dover Corp. - Key offerings
              • Exhibit 150: Dover Corp. - Segment focus
            • 12.11 Impinj Inc.
              • Exhibit 151: Impinj Inc. - Overview
              • Exhibit 152: Impinj Inc. - Product / Service
              • Exhibit 153: Impinj Inc. - Key offerings
            • 12.12 Mettler Toledo International Inc.
              • Exhibit 154: Mettler Toledo International Inc. - Overview
              • Exhibit 155: Mettler Toledo International Inc. - Business segments
              • Exhibit 156: Mettler Toledo International Inc. - Key offerings
              • Exhibit 157: Mettler Toledo International Inc. - Segment focus
            • 12.13 Optel Group
              • Exhibit 158: Optel Group - Overview
              • Exhibit 159: Optel Group - Product / Service
              • Exhibit 160: Optel Group - Key offerings
            • 12.14 Oracle Corp.
              • Exhibit 161: Oracle Corp. - Overview
              • Exhibit 162: Oracle Corp. - Business segments
              • Exhibit 163: Oracle Corp. - Key news
              • Exhibit 164: Oracle Corp. - Key offerings
              • Exhibit 165: Oracle Corp. - Segment focus
            • 12.15 SAP SE
              • Exhibit 166: SAP SE - Overview
              • Exhibit 167: SAP SE - Business segments
              • Exhibit 168: SAP SE - Key news
              • Exhibit 169: SAP SE - Key offerings
              • Exhibit 170: SAP SE - Segment focus
            • 12.16 SATO Holdings Corp.
              • Exhibit 171: SATO Holdings Corp. - Overview
              • Exhibit 172: SATO Holdings Corp. - Business segments
              • Exhibit 173: SATO Holdings Corp. - Key offerings
              • Exhibit 174: SATO Holdings Corp. - Segment focus
            • 12.17 Zebra Technologies Corp.
              • Exhibit 175: Zebra Technologies Corp. - Overview
              • Exhibit 176: Zebra Technologies Corp. - Business segments
              • Exhibit 177: Zebra Technologies Corp. - Key news
              • Exhibit 178: Zebra Technologies Corp. - Key offerings
              • Exhibit 179: Zebra Technologies Corp. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 180: Inclusions checklist
                • Exhibit 181: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 182: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 183: Research methodology
                • Exhibit 184: Validation techniques employed for market sizing
                • Exhibit 185: Information sources
              • 13.5 List of abbreviations
                • Exhibit 186: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              pharmaceutical traceability market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis